drug · small molecule
patient view →mitapivat sulfate
Marketedupdated 2mo agoby $AGIO AGIOS PHARMACEUTICALS, INC.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval, with an approval for familial hemolytic anemia.
indications
investigational
Sickle Cell Disease
targets
Pyruvate kinase PKLR
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that